Simplify Logo

Full-Time

Pioneering Medicines: Scientist

Translational Sciences

Posted on 9/10/2024

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Healthcare
Biotechnology

Mid, Senior

Cambridge, MA, USA

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Requirements
  • An MSc degree (or equivalent) in biology or a related scientific area, with 5+ years of additional research experience; or PhD degree with 2+ years of research experience.
  • Demonstrate technical expertise leveraging cellular, molecular and/or immunological techniques (including but not limited to qPCR, ELISA, MSD, flow cytometry, histology, WB, primary cell or iPSC cultures, and microtissue/organoid models).
  • Experience leveraging a variety of complex in vitro/ex vivo models (e.g. ex vivo stimulation of immune cells; compound characterization in 3D organoids). Ability to work with preclinical model systems and bridge to human assays will be essential.
  • Demonstrate scientific expertise that is directly related to 1 or more of the following areas: cardiovascular, renal, metabolic, immunological/inflammatory, genetic diseases.
Responsibilities
  • Utilize a depth and breadth of scientific expertise to deliver impactful datasets that inform and shape the translational direction of discovery programs (e.g. primary cultures, iPSC-derived models and/or 3D organoid systems, PD biomarker discovery, novel biomarker assay PoC, patient selection).
  • Co-ordinate external research activities at CROs or with collaboration partners.
  • Contribute insights and solutions to establish fit-for-purpose research capabilities.
  • Partner with drug discovery/clinical functions to facilitate transfer of assays, reagents, protocols and/or datasets.
  • Maintain experimental records in an ELN and contribute to the writing of regulatory and/or scientific documents as necessary.
  • Contribute to the scientific evolution of the Translational Sciences team and other prioritized activities and initiatives within the drug discovery group; mentor/coach/train junior lab-based team members.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.
INACTIVE